title: Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
abstract: In a retrospective review of 2400 consecutive liver biopsy specimens, 60 cases with ground-glass hepatocytes were identified, 41 specimens gave a positive reaction to orcein stain and 19 a negative staining. These 19 specimens were obtained from chronic alcoholics who had been admitted to a detoxication program that used aversive drugs and who were hepatitis B surface antigen negative. The use of cyanamide (Colme), an inhibitor of aldehyde dehydrogenase could be documented in 11 instances. In addition to ground-glass hepatocytes, which were periodic acid-Schiff positive and had a periportal or paraseptal distribution, these liver specimens showed a variety of hepatic lesions: cirrhosis in five cases, portal and periportal inflammation in six, triaditis in five, portal fibrosis in two, and minimal changes in one. Patients with shorter courses of cyanamide were those who had less severe histologic lesions. In three patients who had a liver biopsy carried out before the cyanamide treatment ground-glass hepatocytes were not found. These data indicate that ground-glass hepatocytes that stain with periodic acid-Schiff may develop after cyanamide treatment. They are associated with structural hepatic damage of varied severity in patients submitted to a long-term treatment.
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000517:prevention & control; D056486:Chemical and Drug Induced Liver Injury; D003484:Cyanamide / Q000009:adverse effects*; D003486:Cyanides / Q000009:adverse effects*; D003593:Cytoplasm / Q000187:drug effects / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006529:Hepatomegaly; D006801:Humans; D002479:Inclusion Bodies / Q000187:drug effects / Q000473:pathology*; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008107:Liver Diseases / Q000201:enzymology / Q000473:pathology; D008297:Male; D008875:Middle Aged
chemical_list: D003486:Cyanides; D006514:Hepatitis B Surface Antigens; D003484:Cyanamide